![](https://img.einpresswire.com/small/154877/nikang-logo.jpeg)
NiKang Therapeutics Appoints Kelsey Chen, Ph.D., MBA, as Chief Financial Officer
WILMINGTON, DE, UNITED STATES, April 5, 2021 /EINPresswire.com/ -- NiKang Therapeutics Inc. (“NiKang”), a clinical stage biotech company focused on developing innovative small molecule oncology medicines to help patients with unmet medical needs, today …